Company news
Sino Biopharmaceutical Limited (HKEX:1177) news
Sino Biopharmaceutical Limited news releases on 6ix. Latest, Oct 2, 2026: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30…
Press releases & updates
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2026
October 1, 2026
VOLUNTARY ANNOUNCEMENT - ENTER INTO STRATEGIC BIOSIMILARS PARTNERSHIP WITH STADA
September 28, 2026
Sino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International Expansion
August 19, 2026
Sino Biopharmaceutical : Once-Yearly Dosing, Targeting Cardiovascular Disorders, First US Patient Enrolled in China-US Phase II Clinical Trial of Hygieia's Kylo-11
April 9, 2026
Sino Biopharm Releases 2025 Annual Results: Revenue and Net Profit Maintain Double-Digit Growth, Innovative Product Revenue Exceeds RMB 15 Billion
March 26, 2026
Sino Biopharmaceutical : Positive on Dual Endpoints! CTTQ Pharma's Phase III Study of TQB3454 in Bile Duct Cancer Succeeds, Marketing Application to be Submitted
March 12, 2026
Sino Biopharmaceutical : JPM 2026 | Sino Biopharm Leads in siRNA and Tumor Innovation Platforms, M&A Integration Unleashes Long-Term Growth Momentum
January 15, 2026
Sino Biopharmaceutical : World's First CDK2/4/6 Inhibitor Approved for Marketing, Culmerciclib Capsules (Saitanxin®) Reshape the Breast Cancer Treatment Landscape
December 11, 2025
Phrontline Biopharma Raises $60 Million in Pre-A+ Financing to Advance Global Development of Bispecific and Dual-Payload ADCs
November 24, 2025
MediTrust Health and Sino Biopharm Sign Strategic Cooperation Agreement at CIIE 2025 to Advance Drug-Insurance Integration New Model
November 10, 2025
Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results
October 30, 2025
I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences
October 16, 2025
Sino Biopharmaceutical : Biopharm 2025 Interim Results Announcement
August 18, 2025
Global First-in-Class AT2R Antagonist TRD205 Advances to Phase II: First Patient Dosed in Chronic Post-Surgical Neuropathic Pain Trial
May 5, 2025
Sino Biopharmaceutical (1177.HK) Announces 2024 Interim Results
August 13, 2024
Sino Biopharmaceutical : 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
April 29, 2024
Sino Biopharm (1177.HK) Announces 2023 Annual Results
March 29, 2024
Sino Biopharmaceutical (1177.HK) Announces 2023 Interim Results
August 25, 2023
Sino Biopharmaceutical : 2022 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
June 8, 2023
Sino Biopharm (1177.HK) Announces 2022 Annual Results
March 31, 2023
Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion
August 23, 2022
Sino Biopharmaceutical : VOLUNTARY ANNOUNCEMENT - "LENVATINIB MESILATE CAPSULE" OBTAINS DRUG REGISTRATION CERTIFICATE
July 26, 2021
Sino Biopharmaceutical : Donates Cash and Supplies Valued at RMB10 Million to Support Henan for Flood Relief and Preventing Epidemic
July 22, 2021
Sino Biopharmaceutical : 2021 First Quarterly Profit attributable to Owners of the Parent Soars 118.5% to RMB1.91 Billion
May 24, 2021
Sino Biopharmaceutical : VOLUNTARY ANNOUNCEMENT - "PALONOSETRON HYDROCHLORIDE INJECTION" PASSES CONSISTENCY EVALUATION
May 13, 2021
Sino Biopharmaceutical : VOLUNTARY ANNOUNCEMENT - "DASATINIB TABLET" PASSES CONSISTENCY EVALUATION
May 12, 2021
Sino Biopharmaceutical : VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF CHIEF MEDICAL OFFICER
May 10, 2021
Sino Biopharmaceutical : NOTIFICATION OF BOARD MEETING
May 3, 2021
Sino Biopharmaceutical : VOLUNTARY ANNOUNCEMENT - "TIAN NENG" OBTAINS REGISTRATION CERTIFICATE OF FORMULA FOOD FOR SPECIAL MEDICAL PURPOSE
April 29, 2021
Sino Biopharmaceutical : VOLUNTARY ANNOUNCEMENT - "SU QIAN" OBATAINS REGISTRATION CERTIFICATE OF FORMULA FOOD FOR SPECIAL MEDICAL PURPOSE
April 28, 2021
Sino Biopharmaceutical : VOLUNTARY ANNOUNCEMENT - PENPULIMAB OBTAINED BREAKTHROUGH THERAPY DESIGNATION FROM FDA FOR THIRD-LINE TREATMENT OF METASTATIC NASOPHARYNGEAL CARCINOMA
March 29, 2021